Skip to Content

Institute for Cancer Care Innovation

A collaborative effort among physicians, nurses, patients, caregivers and administrators that focuses on innovative approaches to constantly improving the value of MD Anderson cancer care

Who We Are

The Institute for Cancer Care Innovation studies new and existing models of cancer care delivery and reimbursement. Its programs are based around the principles of value-based health care delivery that focuses on the outcomes and costs of care. The Institute, formerly known as the Institute for Cancer Care Excellence, was created in 2008 to demonstrate the value of MD Anderson’s research-driven multidisciplinary care. The Institute has been at the forefront nationally and internationally for its innovative approaches to measurement of the value of our cancer care delivery system. 

With programs designed to measure the outcomes and costs of the care we provide, the Institute provides essential strategies for maintaining MD Anderson’s preeminent position as the nation’s No. 1 provider of cancer care in the United States.  

Key Initiatives

  • Using TDABC and new costing methodologies to better assess value at MD Anderson Cancer Center
  • Evaluating which outcomes are most important to cancer patients
  • Integrating more useful and comprehensive electronic medical and health data into cancer care
  • Working toward better end-of-life experiences
  • Partnering with others inside MD Anderson and outside the system to create better health care

Contact Us


For more information about the Institute, please contact:

Thomas Feeley, M.D.
Head, Institute for Cancer Care Innovation
The University of Texas MD Anderson Cancer Center
1515 Holcombe, Unit 409
Houston, TX 77030
Phone: 713-792-7115
Fax: 713-795-3941
Email: tfeeley@mdanderson.org 

Heidi W. Albright
Director, Institute for Cancer Care Innovation
The University of Texas MD Anderson Cancer Center
1515 Holcombe, Unit 466
Houston, TX 77030
Phone: 713-794-4620
Fax: 713-792-2100
Email: halbright@mdanderson.org 

About Us

Current projects include studies of what outcomes are important to patients with cancer; how patients use our electronic health record; and studies related to understanding the costs of cancer care delivery and how to control those costs.

    Read More